Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Double-Crane to Distribute Sagent Pediatric Drug in China

publication date: Feb 13, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
CR Double-Crane will distribute a Sagent Pharma pediatric orphan drug in China. The product is caffeine citrate, available in injected and oral formulations, which is administered to premature infants (born at less than 33 weeks) to prevent sleep apnea. The two companies say they will add other drugs to the relationship in the future. Financial details were not disclosed. More details....

Stock Symbols: (SHA: 600062) (NSDQ: SGNT)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...